ISTRADEFYLLINE

SynDRA canonical compound SYN0003261 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx
Primary target(s)	ADORA1 \| ADORA2A \| ADORA2B \| ADORA3
Mechanism of action	adenosine receptor antagonist
Indication	dyskinesia \| Parkinson's Disease
Disease area	neurology/psychiatry

All known targets

nourianz
nouriast
KW-6002
KW6002
Istradefilina
Nouriast
Nourianz
KW 6002
Istradefylline [USAN:INN]
Istradefylline (JAN/USAN/INN)
(E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
(E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methylxanthine
8-((1E)-2-(3,4-Dimethoxyphenyl)ethenyl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
8-(2-(3,4-dimethoxyphenyl)ethenyl)-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione
8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione
Istradefylline (KW-6002)
(E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione
8-[(E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methyl-purine-2,6 -dione
(E)- 8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methylxanthine
2GZ0LIK7T4
CHEMBL431770
C20H24N4O4
8-[(E)-2-(3,4-dimethoxyphenyl)vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
UNII-2GZ0LIK7T4
Istradefyline
Istradefylline [USAN:INN:JAN]
NCGC00253737-01
Nourianz (TN)
Nouriast (TN)
8-[(1E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
Istradefylline [USAN]
ISTRADEFYLLINE [MI]
ISTRADEFYLLINE [INN]
ISTRADEFYLLINE [JAN]
MLS006010633
SCHEMBL633262
SCHEMBL633263
GTPL5608